142 related articles for article (PubMed ID: 37071628)
21. The societal burden of haemophilia A. II - The cost of moderate and severe haemophilia A in Australia.
Brown LJ; La HA; Li J; Brunner M; Snoke M; Kerr AM
Haemophilia; 2020 Aug; 26 Suppl 5():11-20. PubMed ID: 32935398
[TBL] [Abstract][Full Text] [Related]
22. Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
Thein HH; Jembere N; Thavorn K; Chan KKW; Coyte PC; de Oliveira C; Hur C; Earle CC
BMC Cancer; 2018 Jun; 18(1):694. PubMed ID: 29945563
[TBL] [Abstract][Full Text] [Related]
23. Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia.
Cronin P; Kirkbride B; Bang A; Parkinson B; Smith D; Haywood P
Asia Pac J Clin Oncol; 2017 Jun; 13(3):160-171. PubMed ID: 27619777
[TBL] [Abstract][Full Text] [Related]
24. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
25. Direct Health Care Costs Associated With Multiple Sclerosis: A Population-Based Cohort Study in British Columbia, Canada, 2001-2020.
Khakban A; Rodriguez Llorian E; Michaux KD; Patten SB; Traboulsee A; Oh J; Lynd LD;
Neurology; 2023 Feb; 100(9):e899-e910. PubMed ID: 36450607
[TBL] [Abstract][Full Text] [Related]
26. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
[TBL] [Abstract][Full Text] [Related]
27. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
28. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
[TBL] [Abstract][Full Text] [Related]
29. Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia.
Tran B; Falster MO; Girosi F; Jorm L
BMJ Open; 2016 Jan; 6(1):e009410. PubMed ID: 26743704
[TBL] [Abstract][Full Text] [Related]
30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
31. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
Marklund M; Zheng M; Veerman JL; Wu JHY
PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
[TBL] [Abstract][Full Text] [Related]
32. Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US.
Bhattacharya K; Bentley JP; Ramachandran S; Chang Y; Banahan BF; Shah R; Bhakta N; Yang Y
JAMA Netw Open; 2021 Jul; 4(7):e2116357. PubMed ID: 34241627
[TBL] [Abstract][Full Text] [Related]
33. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
[TBL] [Abstract][Full Text] [Related]
34. The economic impact of multiple sclerosis in Australia in 2010.
Palmer AJ; Colman S; O'Leary B; Taylor BV; Simmons RD
Mult Scler; 2013 Oct; 19(12):1640-6. PubMed ID: 23652216
[TBL] [Abstract][Full Text] [Related]
35. Health-care costs of underweight, overweight and obesity: Australian population-based study.
Clifford SA; Gold L; Mensah FK; Jansen PW; Lucas N; Nicholson JM; Wake M
J Paediatr Child Health; 2015 Dec; 51(12):1199-206. PubMed ID: 26059311
[TBL] [Abstract][Full Text] [Related]
36. The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis).
Sweeney R; Conroy AB; Dwyer R; Aitken CK
Aust N Z J Public Health; 2009 Aug; 33(4):352-7. PubMed ID: 19689596
[TBL] [Abstract][Full Text] [Related]
37. Healthcare costs associated with prostate cancer: estimates from a population-based study.
Krahn MD; Zagorski B; Laporte A; Alibhai SM; Bremner KE; Tomlinson G; Warde P; Naglie G
BJU Int; 2010 Feb; 105(3):338-46. PubMed ID: 19594734
[TBL] [Abstract][Full Text] [Related]
38. Excess healthcare cost associated with a low smoking prevalence, Barbados.
Lwegaba A
West Indian Med J; 2004 Jan; 53(1):12-6. PubMed ID: 15114887
[TBL] [Abstract][Full Text] [Related]
39. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
[TBL] [Abstract][Full Text] [Related]
40. Direct cost associated with acquired brain injury in Ontario.
Chen A; Bushmeneva K; Zagorski B; Colantonio A; Parsons D; Wodchis WP
BMC Neurol; 2012 Aug; 12():76. PubMed ID: 22901094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
